Article
Successful HCV genotyping of previously failed and low viral load specimens using an HCV RNA qualitative assay based on transcription-mediated amplification in conjunction with the line probe assay.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology - 1 Sept 2003
Comanor Lorraine, Elkin Claudia, Leung Kimmy, Krajden Mel, Kronquist Kathryn, Nicolas Keith, Horansky Evelyn, deMedina Maria, Kittichai Promrat, Sablon Erwin, Ziermann Rainer, Sherlock Chris
Abstract excerpt
BACKGROUND: Hepatitis C virus (HCV) genotyping is a critical part of the diagnostic work-up for chronic hepatitis C. The VERSANT HCV line probe assay (LiPA) marketed by Bayer Corporation requires PCR-derived amplicons for genotyping usually obtained from commercial assays, including Amplicor HCV...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
